Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.

Eric Assenat,Christelle De La Fouchardiere,Caroline Mollevi,Emmanuelle Samalin,Fabienne Portales,Françoise Desseigne,Christophe Carenco,Marie Dupuy,Ernesto Lopez-Martinez,Catherine Fiess,Thibault Mazard,Marc Ychou

Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.

2018

Eric Assenat
Christelle De La Fouchardiere
Caroline Mollevi
Emmanuelle Samalin
Fabienne Portales
Françoise Desseigne
Christophe Carenco
Marie Dupuy
Ernesto Lopez-Martinez
Catherine Fiess
Thibault Mazard
Marc Ychou

4109Background: Folfirinox (FFX) and Nab-paclitaxel/Gemcitabine (AG) showed significant efficacy improvement compared to Gemcitabine alone in metastatic pancreatic cancer (mPC). Alternating AG and ...

Keywords:

Nab-paclitaxel
Sequential treatment
Oncology
Pathology
Gemcitabine
FOLFIRINOX
Metastatic Pancreatic Adenocarcinoma
Internal medicine
Medicine
Metastatic pancreatic cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations